Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
Thrower SL; James L; Hall W; Green KM; Arif S; Allen JS; Van-Krinks C; Lozanoska-Ochser B; Marquesini L; Brown S; Wong FS; Dayan CM; Peakman M; Clinical And Experimental Immunology, 2009, vol. 155, issue 2, p 156, ISSN 13652249. ISBN 13652249.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef